Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
AGI Greenpac Ltd
NSE:AGI
|
IN |
|
B
|
Boston Scientific Corp
F:BSX
|
US |
|
C
|
CONSOL Energy Inc
F:C9X
|
US |
|
Quadrant Televentures Ltd
BSE:511116
|
IN |
|
King Yuan Electronics Co Ltd
TWSE:2449
|
TW |
|
FirstEnergy Corp
NYSE:FE
|
US |
|
Northern Star Resources Ltd
ASX:NST
|
AU |
|
A
|
Asics Corp
OTC:ASCCF
|
JP |
|
Verona Pharma PLC
NASDAQ:VRNA
|
UK |
|
Distribuidora Internacional de Alimentacion SA
OTC:DIDAF
|
ES |
|
Isabella Bank Corp
OTC:ISBA
|
US |
|
Inmode Ltd
NASDAQ:INMD
|
IL |
|
C
|
Carnival PLC
NYSE:CUK
|
UK |
|
Vidrala SA
OTC:VDRFF
|
ES |
|
S
|
Societe BIC SA
OTC:BICEF
|
FR |
|
Cognex Corp
NASDAQ:CGNX
|
US |
|
Naspers Ltd
OTC:NAPRF
|
ZA |
|
R
|
Royal Bafokeng Platinum Ltd
JSE:RBP
|
ZA |
|
A
|
Allkem Ltd
ASX:AKE
|
AU |
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
AU |
|
A
|
Alpha Pro Tech Ltd
AMEX:APT
|
CA |
|
Goldman Sachs Group Inc
NYSE:GS
|
US |
|
DocMorris AG
SIX:DOCM
|
CH |
Bankruptcy Probability
Rigel Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Rigel Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
551.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
177.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Rigel Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Rigel Pharmaceuticals Inc has total debt of 15m USD. This includes both short-term (0 USD) and long-term (15m USD) debt.
You can find a full breakdown on its Balance Sheet.
